161 related articles for article (PubMed ID: 34676996)
41. Dual PI3Kδ/γ Inhibitor Duvelisib Prevents Development of Neuropathic Pain in Model of Paclitaxel-Induced Peripheral Neuropathy.
Adamek P; Heles M; Bhattacharyya A; Pontearso M; Slepicka J; Palecek J
J Neurosci; 2022 Mar; 42(9):1864-1881. PubMed ID: 35042769
[TBL] [Abstract][Full Text] [Related]
42. Paclitaxel-activated astrocytes produce mechanical allodynia in mice by releasing tumor necrosis factor-α and stromal-derived cell factor 1.
Liu X; Tonello R; Ling Y; Gao YJ; Berta T
J Neuroinflammation; 2019 Nov; 16(1):209. PubMed ID: 31707979
[TBL] [Abstract][Full Text] [Related]
43. Spinal CCL2 and microglial activation are involved in paclitaxel-evoked cold hyperalgesia.
Pevida M; Lastra A; Hidalgo A; Baamonde A; Menéndez L
Brain Res Bull; 2013 Jun; 95():21-7. PubMed ID: 23562605
[TBL] [Abstract][Full Text] [Related]
44. Cannabinoid agonist WIN 55,212-2 prevents the development of paclitaxel-induced peripheral neuropathy in rats. Possible involvement of spinal glial cells.
Burgos E; Gómez-Nicola D; Pascual D; Martín MI; Nieto-Sampedro M; Goicoechea C
Eur J Pharmacol; 2012 May; 682(1-3):62-72. PubMed ID: 22374260
[TBL] [Abstract][Full Text] [Related]
45. Cortical astrocytes rewire somatosensory cortical circuits for peripheral neuropathic pain.
Kim SK; Hayashi H; Ishikawa T; Shibata K; Shigetomi E; Shinozaki Y; Inada H; Roh SE; Kim SJ; Lee G; Bae H; Moorhouse AJ; Mikoshiba K; Fukazawa Y; Koizumi S; Nabekura J
J Clin Invest; 2016 May; 126(5):1983-97. PubMed ID: 27064281
[TBL] [Abstract][Full Text] [Related]
46. Characterization of oxaliplatin-induced chronic painful peripheral neuropathy in the rat and comparison with the neuropathy induced by paclitaxel.
Xiao WH; Zheng H; Bennett GJ
Neuroscience; 2012 Feb; 203():194-206. PubMed ID: 22200546
[TBL] [Abstract][Full Text] [Related]
47. Involvement of the chemokine CCL3 and the purinoceptor P2X7 in the spinal cord in paclitaxel-induced mechanical allodynia.
Ochi-ishi R; Nagata K; Inoue T; Tozaki-Saitoh H; Tsuda M; Inoue K
Mol Pain; 2014 Aug; 10():53. PubMed ID: 25127716
[TBL] [Abstract][Full Text] [Related]
48. Prophylactic topical paeoniflorin prevents mechanical allodynia caused by paclitaxel in mice through adenosine A
Andoh T; Kobayashi N; Uta D; Kuraishi Y
Phytomedicine; 2017 Feb; 25():1-7. PubMed ID: 28190463
[TBL] [Abstract][Full Text] [Related]
49. Rosuvastatin Synergistically Enhances the Antinociceptive Efficacy of Duloxetine in Paclitaxel-Induced Neuropathic Pain in Mice.
Lobos N; Lux S; Zepeda RJ; Pelissier T; Marcos JL; Bustos-Quevedo G; Hernández A; Constandil L
Int J Mol Sci; 2023 May; 24(9):. PubMed ID: 37176065
[TBL] [Abstract][Full Text] [Related]
50. A3 adenosine receptor agonist prevents the development of paclitaxel-induced neuropathic pain by modulating spinal glial-restricted redox-dependent signaling pathways.
Janes K; Esposito E; Doyle T; Cuzzocrea S; Tosh DK; Jacobson KA; Salvemini D
Pain; 2014 Dec; 155(12):2560-2567. PubMed ID: 25242567
[TBL] [Abstract][Full Text] [Related]
51. Evidence that spinal astrocytes but not microglia contribute to the pathogenesis of Paclitaxel-induced painful neuropathy.
Zhang H; Yoon SY; Zhang H; Dougherty PM
J Pain; 2012 Mar; 13(3):293-303. PubMed ID: 22285612
[TBL] [Abstract][Full Text] [Related]
52. Mechanisms underlying paclitaxel-induced neuropathic pain: Channels, inflammation and immune regulations.
Xu Y; Jiang Z; Chen X
Eur J Pharmacol; 2022 Oct; 933():175288. PubMed ID: 36122757
[TBL] [Abstract][Full Text] [Related]
53. Notch signaling activation contributes to paclitaxel-induced neuropathic pain via activation of A1 astrocytes.
Li DY; Gao SJ; Sun J; Zhang LQ; Wu JY; Song FH; Liu DQ; Zhou YQ; Mei W
Eur J Pharmacol; 2022 Aug; 928():175130. PubMed ID: 35777441
[TBL] [Abstract][Full Text] [Related]
54. The prophylactic effects of a traditional Japanese medicine, goshajinkigan, on paclitaxel-induced peripheral neuropathy and its mechanism of action.
Matsumura Y; Yokoyama Y; Hirakawa H; Shigeto T; Futagami M; Mizunuma H
Mol Pain; 2014 Sep; 10():61. PubMed ID: 25240613
[TBL] [Abstract][Full Text] [Related]
55. Presynaptic mGluR5 receptor controls glutamatergic input through protein kinase C-NMDA receptors in paclitaxel-induced neuropathic pain.
Xie JD; Chen SR; Pan HL
J Biol Chem; 2017 Dec; 292(50):20644-20654. PubMed ID: 29074619
[TBL] [Abstract][Full Text] [Related]
56. Chemotherapy-evoked painful peripheral neuropathy: analgesic effects of gabapentin and effects on expression of the alpha-2-delta type-1 calcium channel subunit.
Xiao W; Boroujerdi A; Bennett GJ; Luo ZD
Neuroscience; 2007 Jan; 144(2):714-20. PubMed ID: 17084535
[TBL] [Abstract][Full Text] [Related]
57. Inhibition of cytochrome P450c17 reduces spinal astrocyte activation in a mouse model of neuropathic pain via regulation of p38 MAPK phosphorylation.
Choi SR; Beitz AJ; Lee JH
Biomed Pharmacother; 2019 Oct; 118():109299. PubMed ID: 31387001
[TBL] [Abstract][Full Text] [Related]
58. VEGF-A/VEGFR-1 signalling and chemotherapy-induced neuropathic pain: therapeutic potential of a novel anti-VEGFR-1 monoclonal antibody.
Micheli L; Parisio C; Lucarini E; Vona A; Toti A; Pacini A; Mello T; Boccella S; Ricciardi F; Maione S; Graziani G; Lacal PM; Failli P; Ghelardini C; Di Cesare Mannelli L
J Exp Clin Cancer Res; 2021 Oct; 40(1):320. PubMed ID: 34649573
[TBL] [Abstract][Full Text] [Related]
59. Connexin-43 induces chemokine release from spinal cord astrocytes to maintain late-phase neuropathic pain in mice.
Chen G; Park CK; Xie RG; Berta T; Nedergaard M; Ji RR
Brain; 2014 Aug; 137(Pt 8):2193-209. PubMed ID: 24919967
[TBL] [Abstract][Full Text] [Related]
60. Spinal sigma-1 receptor activation increases the production of D-serine in astrocytes which contributes to the development of mechanical allodynia in a mouse model of neuropathic pain.
Moon JY; Choi SR; Roh DH; Yoon SY; Kwon SG; Choi HS; Kang SY; Han HJ; Kim HW; Beitz AJ; Oh SB; Lee JH
Pharmacol Res; 2015 Oct; 100():353-64. PubMed ID: 26316425
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
